相关实验视频

Updated: Sep 9, 2025

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

整合基因组和转录组特征以表征和预测血管免疫T细胞淋巴瘤

Chong Wei¹, Congwei Jia², Yan Zhang¹

¹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Wangfujing Shuaifuyuan, Dongdan, Beijing, 100730, China.

Annals of hematology

|September 4, 2025

概括

这项研究显示,患有更多B细胞和M1巨细胞的血管免疫原型T细胞淋巴瘤 (AITL) 患者对治疗反应更好,生存率更高. 某些基因突变与较差的结果和免疫抑制有关.

科学领域:

免疫学
癌症学
遗传学

背景情况:

血管免疫性T细胞淋巴瘤 (AITL) 是一种具有复杂瘤微环境的侵袭性非霍奇金淋巴瘤.
了解基因突变和免疫细胞透之间的相互作用对于预测AITL患者的结果至关重要.

研究的目的:

研究新诊断的AITL患者的分子形状,免疫细胞透和临床结果之间的关系.
在AITL中确定治疗反应和预后的潜在生物标志物.

主要方法:

从24名AITL患者的转录组和瘤基因组进行综合分析.
基因表达特征以识别丰富的途径.
用于定量透瘤的免疫细胞.
基因突变,免疫细胞丰度和生存数据之间的相关性分析.

主要成果:

较高的B细胞和M1巨细胞透与良好的治疗反应和改善的生存率有显著的关联.
毛囊T辅助细胞 (TFH) 丰度与有利的免疫子组相反相关,并与瘤负担相关.
在RHOA,IDH2和DNMT3A的突变以及TET2突变的高变异异常 (VAF) 与较差的存活率和不利的免疫微环境有关.

结论:

在AITL中具有有利的免疫特征,以增加的B细胞和M1巨细胞为特征,预测化学敏感性和更好的预后.
特定的基因变异 (RHOA,IDH2,DNMT3A突变,高TET2VAF) 与AITL的不良结果和免疫抑制有关.
这项研究强调了瘤遗传学在塑造免疫微环境和影响AITL临床轨迹方面的关键作用.

关键词:

血管免疫性T细胞淋巴瘤基因表达分析瘤基因组预测

更多相关视频

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...